No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy

Mota Talia M.; Rasmussen Thomas A.; Rhodes Ajantha; Tennakoon Surekha; Dantanarayana Ashanti; Wightman Fiona; Hagenauer Michelle; Roney Janine; Spelman Tim; Purcell Damian F. J.; McMahon James; Hoy Jennifer F.; Prince H. Miles; Elliott Julian H.; Lewin Sharon R.

首页> 外文期刊>AIDS >No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy

【24h】

No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy

机译：在抗逆转录病毒治疗中的艾滋病毒感染的个体vorinostat后2年没有不利的安全或病毒学变化

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To determine the long-term effects of vorinostat on safety and virological parameters in HIV-infected individuals on suppressive antiretroviral therapy (ART).

机译：目的：确定Vorinostat对抑制抗逆转录病毒治疗艾滋病毒感染个体安全病毒学参数的长期影响（艺术品）。

著录项

来源
《AIDS》 |2017年第8期|共5页
作者
Mota Talia M.; Rasmussen Thomas A.; Rhodes Ajantha; Tennakoon Surekha; Dantanarayana Ashanti; Wightman Fiona; Hagenauer Michelle; Roney Janine; Spelman Tim; Purcell Damian F. J.; McMahon James; Hoy Jennifer F.; Prince H. Miles; Elliott Julian H.; Lewin Sharon R.;
展开▼
作者单位

Univ Melbourne Peter Doherty Inst Infect &

Immun 786-798 Elizabeth St Melbourne Vic 3010;

Aarhus Univ Hosp Dept Infect Dis Aarhus Denmark;

Univ Melbourne Peter Doherty Inst Infect &

Immun 786-798 Elizabeth St Melbourne Vic 3010;

Univ Melbourne Peter Doherty Inst Infect &

Immun 786-798 Elizabeth St Melbourne Vic 3010;

Univ Melbourne Peter Doherty Inst Infect &

Immun 786-798 Elizabeth St Melbourne Vic 3010;

Univ Melbourne Peter Doherty Inst Infect &

Immun 786-798 Elizabeth St Melbourne Vic 3010;

Alfred Hlth Dept Infect Dis Melbourne Vic Australia;

Alfred Hlth Dept Infect Dis Melbourne Vic Australia;

Univ Melbourne Peter Doherty Inst Infect &

Immun 786-798 Elizabeth St Melbourne Vic 3010;

Univ Melbourne Peter Doherty Inst Infect &

Immun 786-798 Elizabeth St Melbourne Vic 3010;

Burnet Inst Ctr Populat Hlth Melbourne Vic Australia;

Alfred Hlth Dept Infect Dis Melbourne Vic Australia;

Alfred Hlth Dept Infect Dis Melbourne Vic Australia;

Burnet Inst Ctr Populat Hlth Melbourne Vic Australia;

Univ Melbourne Peter Doherty Inst Infect &

Immun 786-798 Elizabeth St Melbourne Vic 3010;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词
acetylation; histone deacetylase inhibitors; HIV; HIV latency; latency reversal; vorinostat;

机译：乙酰化;组蛋白脱乙酰酶抑制剂;艾滋病毒;艾滋病毒潜伏期;潜伏期逆转;vorinostat;

相似文献

外文文献
中文文献
专利

1. No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy [J] . Mota Talia M., Rasmussen Thomas A., Rhodes Ajantha, AIDS . 2017,第8期

机译：在抗逆转录病毒治疗中的艾滋病毒感染的个体vorinostat后2年没有不利的安全或病毒学变化
2. Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study [J] . Chidozie Elochukwu Agu, Ikenna Kingsley Uchendu, Augusta Chinyere Nsonwu, BMC Public Health . 2019,第1期

机译：尼日利亚克瓦拉州接受抗逆转录病毒治疗的病毒学抑制HIV感染者外周动脉疾病的患病率及相关危险因素：一项横断面研究
3. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study [J] . Nathan W. Cummins, Stacey Rizza, Mark R. Litzow, PLoS Medicine . 2017,第11期

机译：同种异体干细胞移植和抗逆转录病毒疗法的分析停止后，HIV感染者的广泛病毒学和免疫学表征：案例研究
4. Effect of highly active antiretroviral therapy (HAART) on lipid abnormalities in HIV-infected patients [C] . Estari Mamidala 2011 international conference on medical information and bioengineering. . 2011

机译：高效抗逆转录病毒疗法（HAART）对HIV感染患者血脂异常的影响
5. Trends in cancer and development of AIDS in HIV-infected individuals before and after implementation of highly active antiretroviral therapy. [D] . Martin, Rose Marie. 2010

机译：在实施高效抗逆转录病毒治疗前后，艾滋病毒感染者的癌症和艾滋病发展趋势。
6. No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy [O] . Talia M MOTA, Thomas A RASMUSSEN, Ajantha RHODES, -1

机译：伏立诺他使用抗逆转录病毒疗法的艾滋病毒感染者两年后无不良安全性或病毒学变化
7. Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study [O] . Chidozie Elochukwu Agu, Ikenna Kingsley Uchendu, Augusta Chinyere Nsonwu, 2019

机译：在尼日利亚克瓦拉州抗逆转录病毒治疗中病毒抑制艾滋病毒感染个体外周血动脉疾病的患病率和相关危险因素：横截面研究
8. Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS [R] . Marconi, V. C., Grandits, G., Okulicz, J. F., 2011

机译：艾滋病病毒感染者抗逆转录病毒治疗后的累积病毒载量和病毒学衰变模式影响CD4恢复和艾滋病

No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy

摘要

著录项

相似文献

相关主题

期刊订阅